The nematode (Ascaris suum) intestine is a location of synergistic anthelmintic effects of Cry5B and levamisole
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1011835 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Paul D E Williams und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America. Hauptthemen laut MEDLINE: Levamisole, Bacillus thuringiensis Toxins, Endotoxins, Hemolysin Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH National Institute of Allergy and Infectious Diseases, NIH, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
A novel group of biocidal compounds are the Crystal 3D (Cry) and Cytolytic (Cyt) proteins produced by Bacillus thuringiensis (Bt). Some Bt Cry proteins have a selective nematocidal activity, with Cry5B being the most studied. Cry5B kills nematode parasites by binding selectively to membrane glycosphingolipids, then forming pores in the cell membranes of the intestine leading to damage. Cry5B selectively targets multiple species of nematodes from different clades and has no effect against mammalian hosts. Levamisole is a cholinergic anthelmintic that acts by selectively opening L-subtype nicotinic acetylcholine receptor ion-channels (L-AChRs) that have been found on muscles of nematodes. A synergistic nematocidal interaction between levamisole and Cry5B at the whole-worm level has been described previously, but the location, mechanism and time-course of this synergism is not known. In this study we follow the timeline of the effects of levamisole and Cry5B on the Ca 2+ levels in enterocyte cells in the intestine of Ascaris suum using fluorescence imaging. The peak Ca 2+ responses to levamisole were observed after approximately 10 minutes while the peak responses to activated Cry5B were observed after approximately 80 minutes. When levamisole and Cry5B were applied simultaneously, we observed that the responses to Cry5B were bigger and occurred sooner than when it was applied by itself. It is proposed that the synergism is due to the cytoplasmic Ca 2+ overload that is induced by the combination of levamisole opening Ca 2+ permeable L-subtype nAChRs and the Ca 2+ permeable Cry5B toxin pores produced in the enterocyte plasma membranes. The effect of levamisole potentiates and speeds the actions of Cry5B that gives rise to bigger Ca 2+ overloads that accelerates cell-death of the enterocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America.
- Department of Veterinary Pathology, Iowa State University, Ames, Iowa, United States of America.
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
ORCID-Profile: Richard J Martin
Förderung
- NIAID NIH HHS
- NIH National Institute of Allergy and Infectious Diseases
- NIH, National Institute of Allergy and Infectious Diseases
- E.A. Benbrook Foundation for Pathology and Parasitology
Zitieren
APA
Williams, P. D. E., Brewer, M. T., Aroian, R. V., Robertson, A. P., & Martin, R. J. (2024). The nematode (Ascaris suum) intestine is a location of synergistic anthelmintic effects of Cry5B and levamisole. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011835
Vancouver
Williams PDE, Brewer MT, Aroian RV, Robertson AP, Martin RJ. The nematode (Ascaris suum) intestine is a location of synergistic anthelmintic effects of Cry5B and levamisole. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011835
BibTeX
@article{Williams2024,
author = {Williams, Paul D E and Brewer, Matthew T and Aroian, Raffi V and Robertson, Alan P and Martin, Richard J},
title = {The nematode (Ascaris suum) intestine is a location of synergistic anthelmintic effects of Cry5B and levamisole},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1011835}
}
EUVIMED